Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pasireotide (signifor) (1 trial)
sulfur hexafluoride lipid-type a microspheres (Lumason) (1 trial)
Angiodysplasia (Phase 2)
Trials (2 total)
Trial APIs (2 total)